BROACH LIFECARE HOSPITAL LIMIT Share Price

Broach Lifecare Hospital Limited is an India-based company, which operates its boutique hospitals under the brand, Maple Hospitals. The Company also provides round-the-clock services to patients with heart ailments, consisting of non-invasive cardiology services, such as two-dimensional (2D) echocardiography, electrocardiography, treadmill test, Holter monitoring, ambulatory blood pressure measurement, stress test and dobutamine stress echocardiography. The Company conducts interventional procedures, such as angiography, angioplasty, pacemaker implantation, cardiac resynchronization therapy, arrhythmia management, peripheral angiography, as well as peripheral angioplasty and congenital heart disease interventions. The Company also conducts complex intervention procedures like using cutter balloons for in-stent blockages, implanting drug-eluting balloons in previously implanted stents, fractional flow reserve and rotablator technology for hard calcified blockages.

BROACH LIFECARE HOSPITAL LIMIT Financial Highlights

• Revenue: BROACH LIFECARE HOSPITAL LIMIT reported revenue of ₹6.03 crore in FY26 vs ₹3.23 crore in FY25. It showed an increase of 86.69% on a yearly basis.
• Operating Profit: BROACH LIFECARE HOSPITAL LIMIT reported an operating profit of ₹0.21 crore in FY26 vs ₹0.72 crore in FY25. It showed a decrease of 70.83% on a year-on-year basis.
• Net Profit: BROACH LIFECARE HOSPITAL LIMIT reported a net profit of ₹0.09 crore in FY26 vs ₹0.54 crore in FY25. It showed a decrease of 83.33% on a yearly basis.